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We investigated the effects of bicarbonate on the growth of several different bacteria
as well as its effects on biofilm formation and intracellular cAMP concentration in
Pseudomonas aeruginosa. Biofilm formation was examined in 96-well plates, with
or without bicarbonate. The cAMP production of bacteria was measured by a
commercial assay kit. We found that NaHCO3 (100 mmol l−1) significantly inhibited,
whereas NaCl (100 mmol l−1) did not influence the growth of planktonic bacteria.
MIC and MBC measurements indicated that the effect of HCO−3 is bacteriostatic
rather than bactericidal. Moreover, NaHCO3 prevented biofilm formation as a function
of concentration. Bicarbonate and alkalinization of external pH induced a significant
increase in intracellular cAMP levels. In conclusion, HCO−3 impedes the planktonic
growth of different bacteria and impedes biofilm formation by P. aeruginosa that is
associated with increased intracellular cAMP production. These findings suggest that
aerosol inhalation therapy with HCO−3 solutions may help improve respiratory hygiene in
patients with cystic fibrosis and possibly other chronically infected lung diseases.
Keywords: cystic fibrosis, bicarbonate, pH, biofilm, Pseudomonas aeruginosa, Staphylococcus aureus, cAMP,
HCO−3
INTRODUCTION
Cystic fibrosis (CF) is caused by mutations in the gene encoding the cystic fibrosis transmembrane
conductance regulator (CFTR) protein (Riordan et al., 1989). CFTR is a cAMP/protein kinase
A (PKA)-dependent epithelial anion channel that conducts both chloride and bicarbonate
(Linsdell et al., 1997; Reddy and Quinton, 2003). Defective transepithelial anion transport impairs
mucociliary clearance (MCC) leading to the retention of thick, viscid mucus in the airways
(Quinton, 2007a, 2010). The poor clearance of viscous CF mucus contributes to a vicious cycle of
airway obstruction, infection, and inflammation (Hoffman and Ramsey, 2013). However, the links
between the primary defect in anion transport and CF lung disease appear to be multifactorial. It
was recently shown that impaired HCO−3 secretion is likely responsible for aggregated mucus in
CF mice (Garcia et al., 2009; Gustafsson et al., 2012) and pigs (Birket et al., 2014).
In addition, the abnormally lower pH of the airway surface liquid (ASL) was associated with
decreased bacterial killing in the CF porcine lung. Aerosolizing a HCO−3 solution onto the CF
porcine airways increased innate bacterial killing in vivo (Pezzulo et al., 2012). Recruitment of
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lymphocytes may promote epithelial HCO−3 secretion during
infection and, intriguingly, epithelial HCO−3 secretion may
require CFTR expression in lymphocytes as yet another
deficiency impacting on CF lung disease (Tang et al., 2012).
For decades, HCO−3 has been used and indicated for use as
a microbial disinfectant in food and agriculture industries, but
usually as an adjuvant (Rutala et al., 2000). Earlier, HCO−3 , in
combination with lidocaine was reported to exert antibacterial
activity (Thompson et al., 1993). Immunologically, it is crucial for
the optimal activity of antimicrobial peptides (Dorschner et al.,
2006) but, apparently, it can have an independent bactericidal
effect on Escherichia coli (Xie et al., 2010). In medicine, it is an
accepted treatment for chlorine gas intoxication (Bosse, 1994)
and has been suggested for use as a mucolytic as well as an
adjuvant for nebulized drug delivery (Kaushik et al., 2016). It
has also been long recommended for dental hygiene (Newbrun
et al., 1984; Drake et al., 1995). Most of the antibacterial reports
on HCO−3 have been limited to planktonic growth and do not
include effects on biofilm formation.
Bicarbonate directly and indirectly affects lung function
(Quinton, 2007a,b). It is required for sequestering calcium and
protons from secreted mucin granules to allow for normal
expansion upon release (Garcia et al., 2009; Quinton, 2010).
It may also affect neutrophil killing capacity as well as
bacterial colonization in the lungs (Quinton, 2007a, 2008; Abou
Alaiwa et al., 2014). Importantly, HCO−3 influences the H+
concentration (pH) of the ASL via the HCO−3 /CO2 buffer system
(Shah et al., 2016a). These effects directly affect the properties of
the ASL and its critical ability to trap inhaled and endogenous
debris for export by the ciliated surfaces of the airways. They
indirectly affect the lungs by maintaining an airway environment
that also enables the immune system to clear viral and bacterial
pathogens. Any maneuver such as adding exogenous HCO−3 , as
suggested here, that improves or helps maintain airway patency
is expected to enhance lung function.
Successful antimicrobial therapy for bacterial lung infections
is crucial for increasing life expectancy and improving CF
patients’ quality of life. In CF lungs, however, bacteria colonize
in biofilms (Rogers et al., 2011), making eradication of pathogens
difficult. It is also known that bacteria in biofilms are more
resistant compared to planktonic cells (Stewart and Costerton,
2001; Venkatesan et al., 2015). Biofilm formation is thought to
be regulated largely by the second messenger molecules cAMP
and c-di-GMP in bacterial cells. An increase in intracellular
cAMP concentrations along with a decrease in c-di-GMP levels
is associated with the production of acute virulence factors and
reduced biofilm formation (Almblad et al., 2015). Accordingly,
HCO−3 stimulates soluble adenylate cyclase (sAC) and increases
the activity of phosphodiesterase that breaks down c-di-GMP
(Chen et al., 2000; Koestler and Waters, 2014a). Of note is that
HCO−3 , CO2, and external pH affect soluble adenylate cyclase
activity and consequently intracellular cAMP levels (Hammer
et al., 2006), which is a hallmark for Pseudomonas aeruginosa
virulence factors that decrease when bacteria form biofilms in
chronic infection (Valentini and Filloux, 2016). Thus, bacterial
life style (planktonic vs. biofilm) is, at least partially, dictated by
intracellular cAMP levels.
Herein, we focus on the effects of HCO−3 on planktonic
growth on several pathogens common to cystic fibrosis and
consider biofilm forming capacity for two of the more prevalent
bacteria in CF, P. aeruginosa and S. aureus. This work presents
a novel proposal that HCO−3 may therapeutically help prevent
colonization and biofilm formation of CF-associated bacteria
by increasing intracellular cAMP levels. Not only do the data
confirm earlier notions, but they also add further reasons to
consider inhaled HCO−3 as a potential therapy, especially in
the context of CF where defective HCO−3 secretion is a well-
established basic defect.
MATERIALS AND METHODS
Growth Experiments
The growth of ATCC control strains and clinical isolates of
different Gram-positive and Gram-negative bacteria in Brain-
Heart Infusion (BHI) broth (Mast Group Ltd., Merseyside,
United Kingdom) were compared with and without 100 mmol
l−1 NaHCO3 in the medium and equilibrated with CO2 to control
pH. Growth experiments were carried out with the following
reference strains: S. aureus ATCC 25923 (MSSA), S. aureus ATCC
29213 (MSSA), S. aureus ATCC 33591 (MRSA), Streptococcus
agalactiae ATCC 80200, Enterococcus faecalis ATCC 29212,
E. faecalis, vanB+, ATCC 51299, P. aeruginosa ATCC 27853,
E. coli ATCC 25922, Haemophilus influenzae ATCC 49766,
H. influenzae ATCC 49247. Some of the experiments were
repeated with clinical isolates of the same species, obtained from
the Central Bacteriological Diagnostic Laboratory of Semmelweis
University, Budapest, obtained from daily routine specimens.
The density of bacterial suspensions was set at 0.5 McFarland
(approximately 108 CFU ml−1) with a VITEK Densichek
apparatus (Biomérieux, Marcy l’Etoile, France). The pH of
the 100 mmol l−1 NaHCO3-containing BHI broth was set at
pH approximately 7.4 by bubbling the autoclaved solution to
equilibration with 20% CO2-balance air for at least 16 h at
37◦C before inoculation. The pH of these unstirred solutions
in hermetically capped bottles remained stable for at least 24 h.
To achieve other pH values, the CO2 concentration required
was calculated from the Henderson–Hasselbalch equation for
the HCO−3 /CO2 buffer system (Story, 2004). When BHI broth
containing 100 mmol l−1 NaHCO3 was equilibrated with 5%
CO2, the measured pH (∼8.5) was somewhat higher than that
calculated from the Henderson–Hasselbalch equation (pH∼8.0).
Aliquots of each suspension (200 µl) were dispensed into
96-well microtiter plates in duplicate. Bacterial suspensions
were then incubated in ambient air (∼0.04% CO2), in 5%
or in 20% CO2 by design. Bacterial growth was followed by
measuring the optical density (OD) at 595 nm using a PR2100
microplate reader (Bio-Rad Laboratories, Hercules, Canada)
60 min after inoculating and subsequently every 15 min for
5.5 h. Optical density of a negative control (without bacterial
growth) was subtracted from all OD values. The results of
the parallel measurements of duplicate samples were averaged
and normalized to the control media. The growth rates were
determined by calculating the area under the curve (AUC)
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(Horváth et al., 2012) using Microsoft Excel, based on the
summation of small trapezoids.
The osmolality of BHI broth was approximately 360 mosm
kg−1 in accordance with the data published earlier (Montgomerie
et al., 1972). Since supplementation of BHI broth with 100 mmol
l−1 NaHCO3 increased the osmolality of the solution to
approximately 470 mosm kg−1, bacterial growth was also
determined in BHI broth containing 100 mmol l−1 NaCl (pH 7.4
adjusted with NaOH) as a control. As a pH control, the growth of
bacteria was measured in unsupplemented BHI broths adjusted
with HCl or NaOH to pH values ranging from 6.8 to 9.0 as
required.
Determination of Minimum Inhibitory
Concentration (MIC) and Minimum
Bactericidal Concentration (MBC) by
Broth Microdilution
To determine MIC and MBC, two strains of P. aeruginosa (ATCC
27853 and a clinical isolate) and two strains of S. aureus (ATCC
29213 and a clinical isolate) were selected. Bacteria were cultured
for 18-20 hours on blood agar plates. The following day, a
0.5 McFarland suspension was prepared in physiological salt
solution. This suspension was diluted 1:20 in Mueller–Hinton
(MH) Broth (cation adjusted). For further measurements this
standardized inoculum was used. NaHCO3 was diluted serially
twofold in MH Broth (cation adjusted) in a plastic microdilution
plate with round bottom wells to a final volume of 0.1 ml. The
concentration of NaHCO3 varied from 1000 to 1.95 mmol l−1
in 10 steps of twofold dilutions. The wells were inoculated with
0.01 ml of standardized inoculum, positive and negative growth
controls were also used. After 24 h incubation, the growth of
bacteria was evaluated based on the visible change of turbidity.
MIC was identified as the lowest concentration of HCO3 at which
no visible growth was observed. To determine MBC, specimens
from the wells without visible bacterial growth were inoculated
onto antibiotic-free agar plates and incubated for 24 h. MBC was
defined as the lowest concentration of HCO3 where no colonies
were observed.
Biofilm Experiments
Although almost all bacteria involved in CF lung disease can form
biofilms, P. aeruginosa presents the largest clinical challenge.
Therefore, we investigated P. aeruginosa for biofilm formation.
Isolates were grown overnight to stationary phase in bouillon
containing meat extract 0.3%, yeast extract 0.2%, pepton 1%,
NaCl 0.5%; pH adjusted to 7.5 with NaOH. The overnight
cultures were diluted 1:100 in the desired medium. All solutions
were prepared by filtration using 0.22 µm filter membranes.
Aliquots of 100 µl of diluted cultures were pipetted into eight
parallel wells of a 96-well microtiter plate. The covered plates
were incubated at 37◦C in ambient air, 5%, or 20% CO2 for
48 h. Planktonic bacteria were then removed by rigorous washing
with PBS three times. Bacteria attached to the wells were air-
dried and subsequently stained with 125 µl of 0.1% crystal violet
solution for 10 min. Excess crystal violet was removed by water-
washing; that is, submerging the plates in tap water several times.
After air-drying, crystal violet was solubilized in 30% acetic acid
(200 µl per well) for 10 min. From each well, 125 µl of this
solution was then transferred to separate wells of an optically
clear, flat-bottom 96-well plate. Optical density was measured at
595 nm in a PR2100 microplate reader (see above) (Merritt et al.,
2011).
To measure the influence of glucose-content on biofilm
formation, the bouillon was supplemented with 0.2, 1.0, 2.0,
and 4.0 g l−1 glucose. Biofilm formation was absent at low
glucose content and was the strongest at 4.0 g l−1 glucose,
consequently all experiments were performed using bouillon
containing 4.0 g l−1 glucose.
Measurement of Intracellular cAMP
Levels
The bacterial production of cAMP was determined with
the Cyclic AMP XP R© Assay Kit (Cell Signaling Technology,
Leiden, Netherlands, originally designed for eukaryotic cells,
but applicable for bacteria as well). Bacterial cultures were first
grown in the desired medium for 15–16 h to stationary phase
for conditioning, then diluted 1:500 in 10 ml of the same fresh
medium and allowed to grow for a few hours until reaching log
phase, that is, OD595 = 0.4–0.5. Cultures were then centrifuged
(4000 × g, 5 min), bacteria were re-suspended in 200 µl of the
kit lysis buffer for 30 min on ice and centrifuged again (8000× g,
5 min); 50 µl of the supernatant was transferred to the assay plate.
According to kit protocol, absorbance was measured at 450 nm in
a PR2100 microplate reader.
Statistical Analysis
For statistical analysis Statistica for Windows 7.0 (Statsoft) was
used. Data presented are means± SD, if not indicated otherwise.
The values were compared using ANOVA followed by LSD
post hoc comparison test. Changes were considered statistically
significant at P < 0.05.
RESULTS
Reduction of Bacterial Growth by
Bicarbonate
Since high external HCO−3 concentrations and/or alkaline pH
are reported to inhibit the growth of E. coli (Xie et al., 2010),
we tested the effect of HCO−3 on the growth of E. coli. The
growth rate of bacteria was significantly inhibited in BHI
broth supplemented with 100 mmol l−1 NaHCO3 (pH 7.4,
equilibrated with 20% CO2) as compared to control media (pH
7.4) without added HCO−3 (Figure 1A). We tested the growth
of bacteria in BHI broth supplemented with 100 mmol l−1
NaCl (pH 7.4; ∼ 1110 mosm kg−1), which did not suppress
the growth of bacteria, indicating that the inhibitory effect
of NaHCO3 was not due to increased osmolality or ionic
strength.
Next, we tested whether alkaline pH affects bacterial growth.
In BHI broth at pH 8.5, the growth capacity was not significantly
influenced (Figure 1A); however, when bacteria were incubated
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FIGURE 1 | Growth of (A) Escherichia coli, (B) Pseudomonas aeruginosa, (C) Staphylococcus aureus, (D) Streptococcus agalactiae, (E) Enterococcus faecalis, and
(F) Haemophilus influenzae in BHI broth supplemented with NaHCO3 compared to control conditions (•: control pH = 7.4, N: 100 mmol l−1 NaCl, pH = 7.4).
Bicarbonate-containing solutions were equilibrated with either 5% (: 100 mmol l−1 NaHCO3, pH = 8.5) or 20% CO2 (: 100 mmol l−1 NaHCO3, pH = 7.4). In the
absence of bicarbonate, pH was adjusted to 8.5 with NaOH (◦: growth at pH = 8.5). Each curve shows the average of two parallel experiments. Standard Deviations
were generally less than 1% of the mean and are not shown. Note that in panel (F) the scale on the y axis differs from the other panels.
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TABLE 1 | Calculated AUC values of different bacteria, based on growth curves in Figures 1A–F.
Bacterium Growth control pH = 7.4 Growth at pH = 8.5 100 mM NaCl pH = 7.4 100 mM NaHCO3 pH = 7.4 100 mM NaHCO3 pH = 8.5
E. coli 2.45 2.82 3.04 1.57 1.49
P. aeruginosa 2.05 1.92 1.82 1.01 1.06
S. aureus 2.48 2.41 2.93 1.92 1.76
S. agalactiae 2.84 2.20 2.48 1.27 1.35
E. faecalis 2.90 3.21 3.18 1.64 1.54
H. influenzae 1.28 1.26 1.31 1.05 1.07
in BHI broth supplemented with 100 mmol l−1 NaHCO3
at pH 8.5 (5% CO2), the inhibitory effects were similar to
those observed at pH 7.4 (20% CO2) (Figure 1A). Thus, the
data show that NaHCO3 per se inhibited bacterial growth,
which was not simply due to higher osmolality or alkaline
media.
In order to test whether the inhibitory effect of HCO3
is specific to E. coli cells, we investigated other species such
as P. aeruginosa, S. aureus, S. agalactiae, E. faecalis, and
H. influenzae. Similarly to the effects on E. coli, NaHCO3
(100 mmol l−1) significantly inhibited the growth of all these
species as well, suggesting that HCO−3 can suppress bacterial
growth in general (Figures 1B–F). In order to compare the
growth rates of bacteria under different conditions more
quantitatively, AUC values were determined as a measure of
the reduced growth rates in HCO−3 -enriched medium for each
bacterial specie (Table 1).
In the previous experiments, to maintain the initial pH of
the media near 7.4, all bicarbonate-containing solutions were
equilibrated with calculated levels of CO2. Therefore, we asked
the question whether HCO−3 -containing media without CO2
equilibration influences growth of P. aeruginosa. Despite the fact
that media pH continued to increase during the exponential
growth phase (i.e., the first six hours), bacterial density remained
similar to those observed with CO2 equilibration (Figures 2A,B).
When bacteria were grown until reaching the stationary phase
(i.e., 24 h), significant increases in OD values were observed in
the presence of both 25 and 100 mmol l−1 HCO−3 suggesting
that HCO−3 is bacteriostatic rather than bactericidal. Of note
is that a lower bacterial density was observed at 24 h when
100 mmol l−1 HCO−3 was present, but it should be kept in
mind that excessive alkalinization at atmospheric CO2 levels,
may exert inhibitory effects on growth rate (Figure 2A).
Nonetheless, HCO−3 -containing media of concentrations up to
100 mmol l−1 equilibrated with appropriate levels of CO2 did
not inhibit maximal bacterial growth at 24 h, suggesting that the
bacteriostatic effects of HCO−3 occur within the initial period
of the exponential growth phase (Figure 2B). We obtained
similar results when the above experiments were repeated with
S. aureus, at least with respect to bacterial growth profile
(Figures 3A,B).
Results of the MIC and MBC
Determination
In the case of all four tested isolates, an MIC of 125 mmol
l−1 was obtained. The MBCs for the two P. aeruginosa strains
were 500 mmol l−1, meanwhile the two S. aureus isolates
remained alive even in the highest HCO−3 concentration tested
(MBC> 1000 mmol l−1).
Bicarbonate Inhibits Biofilm Formation of
P. aeruginosa
One of the most severe complications of CF lung disease
involves biofilm formation of pathogenic bacteria, which
may be due to depleted levels of HCO−3 in CF airways.
Thus, we asked the question whether HCO−3 could not only
inhibit planktonic bacterial growth, but biofilm formation as
well. Glucose starvation leads to impaired biofilm formation
associated with elevated cAMP levels (Huynh et al., 2012),
hence glucose is required for optimal biofilm formation.
Similarly, our data show that although bacteria achieved
high density (OD595 = 0.94 ± 0.12, n = 7), no biofilm was
detected in the medium without added glucose (Figure 4).
On the other hand, in the presence of glucose, bacterial
growth was similar (OD595 = 0.81 ± 0.06, n = 7) and robust
biofilm formation was observed. However, the supplementation
of glucose-containing medium with 100 mmol l−1 HCO−3
prevented biofilm formation and significantly inhibited
planktonic growth as well (OD595 = 0.45 ± 0.04, n = 8). To
demonstrate the reduced number of viable cells in HCO−3 -
containing media, a bacteria count was performed after 48 h’
incubation. In the absence of HCO−3 , the calculated CFU
in bouillon with and without glucose was 2.8 × 1012 and
4.5 × 1011, respectively. In contrast, the average CFU ml−1
was 6.6 × 106 in media supplemented with 100 mmol l−1
HCO−3 . In addition, 50 mmol l−1 HCO
−
3 partially blocked
biofilm formation suggesting a concentration-dependent
inhibitory mechanism (Figure 4). When NaCl (100 mmol l−1)
replaced NaHCO3, biofilm formation capacity was fully
maintained.
Bicarbonate Increases Intracellular
cAMP Levels in Bacteria
Inhibition of biofilm formation may be induced by HCO−3 effects
on the levels of cAMP and c-di-GMP. Thus, we investigated
the effects of HCO−3 on intracellular cAMP production in
P. aeruginosa. Supplementation of BHI medium with 25 and
100 mmol l−1 HCO−3 resulted in significant concentration-
dependent increases in cAMP levels (Figure 5A). Importantly,
administration of 100 mmol l−1 NaCl did not influence cAMP
concentrations (Figure 5A). Since it is well known that sAC
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FIGURE 2 | Changes in bacterial density of Pseudomonas aeruginosa and media pH following 6 vs. 24 h incubations either (A) in air atmosphere, or (B) in the
presence of appropriate levels of CO2. Black bars: NaHCO3-free controls, gray bars: 25 mmol l−1 NaHCO3; striped bars: 100 mmol l−1 NaHCO3. Statistically
significant, ∗P < 0.05.
activity depends on intracellular pH (Rahman et al., 2013), we
tested the effects of media pH changes between 6.0 and 9.0 on
cAMP production. In this pH range, a slight increase in cAMP
levels, parallel to alkalinization was observed (Figure 5B). Of
note, even the highest pH-induced increase in cAMP level was
significantly lower than the increase induced by 100 mmol l−1
HCO−3 . Similar results were obtained when the experiments were
repeated with S. aureus (Figure 5A). Taken together, the data
suggest that biofilm suppression by HCO−3 is mediated through
an increased production of intracellular cAMP.
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FIGURE 3 | Changes in bacterial density of Staphylococcus aureus and media pH following 6 vs. 24 h incubations either (A) in air atmosphere or (B) in the presence
of appropriate CO2 levels. Black bars: NaHCO3-free controls, gray bars: 25 mmol l−1 NaHCO3, striped bars: 100 mmol l−1 NaHCO3. ∗P < 0.05.
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FIGURE 4 | Biofilm formation capacity of Pseudomonas aeruginosa in glucose-containing bouillon (4 g l−1) in the presence of sodium chloride and two different
concentrations of sodium bicarbonate. Please note that in the absence of glucose no biofilm formation was observed. ∗∗∗P < 0.001.
DISCUSSION
Early studies using the human serous cell line (Calu-3) showed
that airway-derived epithelial cells can secrete HCO−3 (Lee et al.,
1998). Recently, active HCO−3 secretion was demonstrated in
native intact small airway epithelium as well (Shamsuddin and
Quinton, 2014). Loss of HCO−3 secretion seems to be associated
with different pathological consequences in CF airways, such
as formation of thickened mucus (Quinton, 2010), reduced
microbial susceptibility to antimicrobial peptides (Dorschner
et al., 2006) and impaired bacterial killing capacity (Pezzulo et al.,
2012; Abou Alaiwa et al., 2014). Therefore, the delivery of HCO−3
into the airways may be potentially therapeutic in CF (Pezzulo
et al., 2012; Li et al., 2016). Moreover, beyond CF, decreased pH
(likely due to decreased HCO−3 ) of airway surface liquid and
chronic bacterial infections have also been described in other
chronic airway diseases such as COPD (Mall and Hartl, 2014; Li
et al., 2016; Shah et al., 2016a,b).
A shift to either acidic or alkaline external pH presents a
stress for bacteria, which may influence survival and growth
(Padan et al., 2005). In alkaline environments the growth
rate of neutrophilic bacteria is reduced (Maurer et al., 2005).
When grown in media at pH 7.0, E. coli cells exhibit shorter
generation time compared to that when it is cultured at pH
8.7 (Maurer et al., 2005). Our data show that 100 mmol l−1
NaHCO3 significantly inhibit the growth of E. coli equally,
at both pH 7.4 and 8.5, but in the absence of HCO−3 ,
neither alkaline pH (up to 8.5) nor equivalent increases in
osmolality (NaCl) inhibit bacterial growth, indicating that HCO−3
per se plays a pivotal role in growth suppression. Alkaline
conditions may alter cytosolic pH of bacteria when protons
must be taken up from the extracellular medium. Under alkaline
conditions proton scavengers markedly decrease E. coli viability
(Vanhauteghem et al., 2013). This phenomenon can be explained
by partitioning of unprotonated scavengers into the cytosol where
they become protonated and increase cytosolic pH. To maintain
pH homeostasis, bacteria require high ATP consumption and
membrane hyperpolarization. We surmise that higher HCO−3
concentrations in the media increase the gradient for increased
HCO−3 entry into the cytosol of bacteria elevating intracellular
pH. The higher energy consumption occurs at the expense of
bacterial growth rate. Importantly, similar results were observed
with S. aureus, P. aeruginosa, S. agalactiae, E. faecalis, and
H. influenzae as well, again suggesting that HCO−3 might be used
to inhibit the growth of bacteria more generally.
S. aureus and P. aeruginosa are of particular interest because
of their high incidence in CF patients with chronic pulmonary
infections. We observed that during the first few hours of
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FIGURE 5 | Differences in intracellular cAMP production of bacteria influenced by (A) sodium chloride and two different concentrations of sodium bicarbonate
(P. aeruginosa and S. aureus), and (B) external pH (P. aeruginosa). ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
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growth S. aureus decreased, whereas P. aeruginosa increased
the pH of the medium. These data suggest that HCO−3 , rather
than pH shifts, suppressed bacterial growth. In P. aeruginosa
these observations were confirmed in HCO−3 -containing media
without CO2 equilibration where despite the increase in the
pH of the media, the growth rate was similar to that detected
with CO2 equilibration. Extending the incubation to 24 h clearly
demonstrated that the effects of HCO−3 were bacteriostatic rather
than bactericidal. Furthermore, in the absence of CO2 a critically
high pH (>9.2) occurred with a reduced growth rate.
Recurrent lung infections caused by long-term colonization
of biofilm-forming bacteria are a significant threat for CF
patients (Høiby et al., 2017). Importantly, NaHCO3 disrupts
oral biofilms in vitro (Pratten et al., 2016). NaHCO3 in
combination with sodium metaperiodate and sodium dodecyl
sulfate also suppressed the formation of P. aeruginosa biofilms
(Gawande et al., 2008). We also confirmed these observations
as NaHCO3 prevented biofilm formation at 100 mmol l−1
and inhibited the planktonic growth of bacteria. Since the
administration of equimolar NaCl (100 mmol l−1) had no effect
and lower concentrations of NaHCO3 only partially blocked
biofilm formation, we concluded that in our experimental model
HCO−3 suppresses bacterial conversion to biofilms as a function
of concentration. These observations may be therapeutically
promising as our unpublished data suggest that 100 mmol l−1
NaHCO3 does not have toxic effects on airway epithelial cells
in vitro.
Biofilm formation requires coordination between cAMP and
c-di-GMP signaling in several bacteria. In P. aeruginosa increased
levels of c-di-GMP suppress signaling from the cAMP-virulence
factor regulator pathway and the expression of virulence
factors that favor a persistent biofilm state (Almblad et al.,
2015). On the other hand, cAMP stimulates the production
of acute virulence factors, but inhibits biofilm formation in
Vibrio cholerae (McDonough and Rodriguez, 2011). Likewise,
HCO−3 also activates virulence gene expression in V. cholerae
(Iwanaga and Yamamoto, 1985; Abuaita and Withey, 2009).
In the intestinal lumen, HCO−3 apparently suppresses the bile-
mediated induction of c-di-GMP that inhibits biofilm formation
(Koestler and Waters, 2014b). Based on the above observations,
we speculated that HCO−3 should increase bacterial cAMP levels.
In fact, our data show that NaHCO3 stimulates intracellular
cAMP concentrations in both P. aeruginosa and S. aureus.
The stimulatory effect was not observed in the presence of
equivalent NaCl concentrations indicating a specific role for
HCO−3 . Interestingly, however, cAMP production was dependent
on external pH in the range between 6.0 and 9.0. These results
are consistent with the findings that sAC is regulated by various
environmental signals such as calcium and CO2/HCO−3 /pH
(McDonough and Rodriguez, 2011; Rahman et al., 2013). Chen
et al. (2000) previously demonstrated that sAC functions as
a HCO−3 sensor in many biological systems. More recently,
HCO−3 has been shown to increase cAMP production via sAC
stimulation in corals (Barott et al., 2013). Thus, we surmise
that reduced HCO−3 secretion from CF lung epithelial cells
results in decreased luminal pH, which leads to decreased levels
of cAMP production in bacterial cells. Low bacterial cAMP
levels reduce virulence factor production, and thus, fail to alert
the innate host immune systems, allowing for more favorable
conditions for biofilm formation. Parallel to these events, elevated
concentrations of c-di-GMP may also support biofilm formation,
making eradication of bacteria from the airways difficult.
CONCLUSION
Since we found that increased HCO−3 impedes the growth and
biofilm formation of several pulmonary bacterial pathogens,
we expect that increasing HCO−3 in the airways may reduce
infection, inflammation, and a consequent tissue damage in the
lungs. We assume that the inhalation of aerosolized HCO−3
could prove therapeutic against bacteria such as S. aureus and
P. aeruginosa, which are among the most relevant pathogens in
lung infections in CF. Although inhalation therapy is inherently
episodic and therefore the concentration of HCO−3 on the
airways is certain to dissipate between inhalation intervals, the
therapy may offer significant benefits even with only acute
changes in the airway surface liquid composition by depressing
bacterial growth repetitively and by increasing the ability of
the innate immune system to reduce or clear the infection
load. However, caution should be taken with treatments that
may affect intracellular cAMP levels because increasing cAMP
may enhance the expression of virulence factors and lead
to acute exacerbation in CF patients with chronic bacterial
infections (Coggan and Wolfgang, 2012). Routinely, CF patients
are treated repeatedly with different courses of antibiotics
in spite of growing concerns over antibiotic side effects.
Although antagonistic effects of HCO−3 have been reported
for tobramycin efficacy (Kaushik et al., 2016), our unpublished
preliminary data suggest that the efficacy of both erythromycin
and imipenem increases in an alkaline environment. Based on
these observations, HCO−3 , inhaled regularly, may reduce use of
antibiotics.
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